Recent studies found that some red algae-derived terpenoids can inhibit both GPX4 and FSP1, thereby blocking the drug resistance pathway of tumor cells, which provides a direction for the development of multi-target ferroptosis inducers [105]. This evidence concerns the gene GPX4 and neoplasm.